Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

HIV-gp140-Specific Antibodies Generated From Indian Long-Term Non-Progressors Mediate Potent ADCC Activity and Effectively Lyse Reactivated HIV Reservoir

Frontiers in Immunology(2022)10.3389/fimmu.2022.844610Source: DataRank Database

HIV-gp140-Specific Antibodies Generated From Indian Long-Term Non-Progressors Mediate Potent ADCC Activity and Effectively Lyse Reactivated HIV Reservoir is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.36)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Rajani Bagul,Madhuri Thakar ORCID,Jayshree R. Dhande

Live enrichment

PubMed:35309295 PMC:PMC8924355 OpenAlex:https://openalex.org/W4214884779

Indian Council of Medical Research

FWCI

0.36

Citation Percentile

0.6%

Citation Trend

2022

2023

2025

2026

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.844610/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.844610/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.844610/full

journalhttps://doi.org/10.3389/fimmu.2022.844610

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35309295

Fields of Study

HIV Research and TreatmentImmune Cell Function and InteractionHIV/AIDS drug development and treatmentAntibody-Dependent Cell CytotoxicityElite ControllersHIV AntibodiesHIV InfectionsHIV-1Humansenv Gene Products, Human Immunodeficiency Virus

MeSH Terms

Elite ControllersAntibody-Dependent Cell CytotoxicityHumansHIV AntibodiesHIV-1HIV Infectionsenv Gene Products, Human Immunodeficiency Virus

Keywords

Antibody-dependent cell-mediated cytotoxicityAntibodyImmunologyPotencyCytotoxicityVirologyIn vitroBiologyMonoclonal antibodyLong-term Non-progressorsAntibody-dependent Cellular Cytotoxicity (Adcc)Hiv-Gp140 AntibodiesHiv-Specific Memory B CellsReactivated Latent Reservoirs

Sustainable Development Goals

SDG 0: Good health and well-being